OMAHA - Testing potential treatments for COVID-19 in controlled clinical trials is the only way to keep patients safe — and the only way to find treatments that really work, a University of Nebraska Medical Center researcher wrote this week. Dr. Andre Kalil, a professor at UNMC and infectious diseases physician with Nebraska Medicine, wrote about the need for careful testing of potential treatments for the novel coronavirus in an opinion piece published online in the Journal of the American Medical Association.

“We have to do the right science that is going to protect patients from getting hurt … and we need a cure,” he said in an interview. “And we cannot find a cure if we don’t do these studies.”

Kalil is leading the UNMC arm of a national trial of an experimental antiviral drug called remdesivir. So far, about 100 patients, all with more serious cases of COVID-19 affecting the lungs, have been enrolled nationwide.

View the article HERE